Skip to main content
TipRanks
Go Ultimate75% OFF

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Cash flow

2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow

HK:9989's free cash flow for Q3 2026 was ¥646.46M. For the 2026 fiscal year, HK:9989's free cash flow was decreased by ¥-39.69M and operating cash flow was ¥686.15M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Mar 22
¥ 1.71B¥ 2.19B¥ 398.22M¥ -756.61M¥ -6.63M
¥ -872.75M¥ -415.05M¥ 1.22B¥ 249.84M¥ 719.93M
¥ -1.09B¥ -2.14B¥ -1.21B¥ 329.56M¥ -501.08M
¥ 1.19B¥ 1.42B¥ 1.77B¥ 1.32B¥ 1.48B
¥ 1.59B¥ 1.99B¥ -46.66M¥ -979.03M¥ -200.49M

Currency in CNY

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow

-3B-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing